Enanta Pharmaceuticals
ENTA
#7477
Rank
ยฃ0.31 B
Marketcap
ยฃ10.74
Share price
-1.84%
Change (1 day)
58.87%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -ยฃ65.73 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ64.8 Million. In 2024 the company made an earning of -ยฃ72.51 Million, an increase over its 2023 earnings that were of -ยฃ95.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ65.73 Million-9.35%
2024 -ยฃ72.51 Million-23.87%
2023 -ยฃ95.24 Million4.39%
2022 -ยฃ91.24 Million-4.4%
2021 -ยฃ95.44 Million91.12%
2020 -ยฃ49.94 Million-407.13%
2019 ยฃ16.25 M-78.63%
2018 ยฃ76.09 M117.97%
2017 ยฃ34.9 M-574.65%
2016 -ยฃ7.36 Million-110.83%
2015 ยฃ67.93 M-4.5%
2014 ยฃ71.12 M-638.53%
2013 -ยฃ13.21 Million-137.98%
2012 ยฃ34.77 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AbbVie
ABBV
ยฃ1.24 B-2,025.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ24.21 B-37,685.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ3.33 B-5,276.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ17.25 B-26,889.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ6.00 B-9,419.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ12.27 B-19,149.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland